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Metabolic flux is in part regulated by endogenous
small molecules that modulate the catalytic activity
of an enzyme, e.g., allosteric inhibition. In contrast
to transcriptional regulation of enzymes, technical
limitations have hindered the production of a
genome-scale atlas of small molecule-enzyme regu-
latory interactions. Here, we develop a framework
leveraging the vast, but fragmented, biochemical
literature to reconstruct and analyze the small mole-
cule regulatory network (SMRN) of the model organ-
ism Escherichia coli, including the primary metabo-
lite regulators and enzyme targets. Using metabolic
control analysis, we prove a fundamental trade-off
between regulation and enzymatic activity, and we
combine it with metabolomic measurements and
the SMRN to make inferences on the sensitivity of
enzymes to their regulators. Generalizing the anal-
ysis to other organisms, we identify highly conserved
regulatory interactions across evolutionarily diver-
gent species, further emphasizing a critical role for
small molecule interactions in the maintenance of
metabolic homeostasis.
INTRODUCTION
Despite nearly a century of accumulated experimental data on
the identity, biophysical nature, and structural basis of small
molecule regulation of enzymes, there has been little progress
in elucidating at genome-scale the regulation of enzymes by
small molecules. Such interactions, e.g., allosteric regulation or
competitive inhibition, play an essential role in homeostasis
and in fast adaptations to abrupt environmental changes. For
instance, feedback inhibition of amino acid biosynthesis path-2666 Cell Reports 20, 2666–2677, September 12, 2017 ª 2017 The A
This is an open access article under the CC BY license (http://creativeways by end products preserves anabolic resources when suffi-
cient levels of amino acids are available (Stryer et al., 2002).
In contrast, the ultrasensitive feedforward activation of PEP
carboxylase by fructose bisphosphate in glycolysis enables
Escherichia coli to rapidly import glucose following periods of
carbon starvation (Xu et al., 2012a).
Recently, it has been established that properly accounting for
the activation/inhibition of enzymes by endogenous small mole-
cules can lead to metabolic models that explain experimental
data better (Chandra et al., 2011; Hackett et al., 2016; Khodayari
and Maranas, 2016; Link et al., 2013; Xu et al., 2012a), facilitate
engineering of novel metabolic pathways (Chen et al., 2015; He
et al., 2016), and improve our understanding of metabolic
phenomena in health and disease (Christofk et al., 2008). So
far, high-throughput experimental assays for discovering small
molecule regulatory interactions have been technically limited
(Feng et al., 2014; Li et al., 2013; Nikolaev et al., 2016; Orsak
et al., 2012; Reinhard et al., 2015; Savitski et al., 2014), while
hybrid approaches that integrate experimental data with compu-
tational models are not scalable and typically focus on central
carbon metabolism (Hackett et al., 2016; Link et al., 2013,
2014; Schueler-Furman and Wodak, 2016).
An alternative strategy for studying small molecule regulation
is to leverage the vast record of biochemical studies to informati-
cally reconstruct a small molecule regulatory network (SMRN)
(Alam et al., 2017). Such an approach would produce a network
of interactions between enzymes and metabolites/small mole-
cules (terms we use interchangeably here) that mirrors the native
interactions of metabolites as substrates for enzymes and could
be naturally integrated with genome-scale metabolic models
(GSMMs, e.g., Biochemical, Genetic and Genomic [BiGG]
models; King et al., 2016), which are in wide use today. An infor-
matic approach would likely cover a larger swath of metabolism,
including peripheral and rarely studied pathways, by aggregating
experimental data from many reports. Furthermore, reports of
small molecule/enzyme regulation from separate publications
could provide additional, independent evidence for such anuthors.
commons.org/licenses/by/4.0/).
ChEBI
BiGGBRENDA
Dataset
EC numbers
met. names
rxn names
K  valuesm
K  valuesI ...
Data
Analysis
Small Molecule
Regulatory Network
KI
Km
M E
Topological
Properties
Kinetics
Statistics
Function of
 Interactions
BIOCYC
KM regulation KI
all entries 130759 303053 37461
mapping to iJO1366 E. coli model 2391 2729 243
unique metabolite-enzyme pairs 981 1669 184
unique metabolites 391 321 110
unique enzymes 398 364 95
Figure 1. Framework for Reconstruction
and Analysis of the Small Molecule Regula-
tory Network
The BRENDA and BioCyc databaseweremined for
each reaction taking place in E. coli. The identified
entries (including data on EC numbers, enzyme
names, activating or inhibiting small molecule-
enzyme interactions, metabolite names, and KM
and KI values) were stored and then matched by
EC number to reactions in the most recent
genome-scale reconstruction of E. coli, iJO1366.
This dataset was searched and analyzed for reg-
ulatory small molecules, yielding a comprehensive
SMRN. The SMRN was used as the primary
resource for the remainder of the analysis. We
analyzed the topological properties of the SMRN,
evaluated the similarities and differences in the
kinetic properties of reactions and interactions,
and used published metabolite concentration data
in order to evaluate the functional role of inhibitory
small molecule-enzyme interactions.interaction. Finally, an informatically reconstructed SMRNwould
also offer a window to distilling how the critical regulatory com-
ponents of the cell, i.e., the regulating metabolites and the regu-
lated enzymes, fit into the broader hierarchy of processes con-
trolling metabolic flux, from thermodynamics to transcriptional
regulation.
Here, we report a computational framework for investigating
small molecule regulation across the complete metabolism
of an organism. Using E. coli as a model, we assemble a
genome-scale SMRN by mining the Braunschweig Enzyme
Database (BRENDA) (Chang et al., 2009, 2015) and BioCyc data-
base (Caspi et al., 2016). The resulting atlas of small molecule
regulation captures widespread inhibition and activation of
metabolic enzymes by endogenous metabolites. Overlaying
this network onto a genome-scale metabolic model of E. coli en-
ables a direct comparison between the topology of metabolism
and its regulatory scaffolding. Integrating the SMRN with exper-
imentally determined metabolite concentrations and binding
affinities exposes how cells balance between the dual roles of
small molecules (i.e., as substrates or inhibitors) as well as their
condition-dependent contribution to metabolic flux regulation.
Finally, by a natural extension of our approach, we compare
the incidence of small molecule regulatory interactions across
phylogenetic taxa spanning all kingdoms of life, revealing a
handful of canonical regulatory interactions that permeate the
metabolism of widely divergent species.
RESULTS
Assembling an SMRN
In contrast to the proliferation (Orth et al., 2011; Thiele et al.,
2009) and automated reconstruction (Henry et al., 2010) of
genome-scale metabolic models, no analogous computational
pipeline is available for the analysis of enzyme regulation by
small molecules. Here we describe a pipeline for mining existing
data on small molecule regulation from public repositories and
computational tools for integrating it with a curated, genome-
scale metabolic model (Figure 1).Our general approach relies on the BRENDA and BioCyc
database for data concerning the inhibition or activation of
enzymes by small molecules in a particular organism. To facili-
tate comparison across species, information in these data-
bases is organized along Enzyme Commission (EC) numbers,
which functionally classify enzymes according to the reaction
they catalyze. Thus, for every EC number, we obtained a list
of possible regulating small molecules, the type of interaction
(activation versus inhibition), and the interaction constant (KI),
if available. In addition to gathering data on the presence
of a small molecule interaction, we also compiled available in-
formation on the Michaelis-Menten constants for the substrates
of each metabolic reaction. The computational pipeline is
freely available for download at https://github.com/eladnoor/
small-molecule-regulation.
Because of its well-defined genome, highly curated metabolic
network, and heavily studied metabolism, we decided to focus
on the model bacterium E. coli. The assembled data described
above was mapped onto a genome-scale metabolic reconstruc-
tion of E. coli (Orth et al., 2011), producing an SMRN (Table S1).
Importantly, our computational framework can be extended
with minimal effort to reconstruct and analyze the SMRN of
other organisms besides E. coli, provided that a genome-scale
metabolic model is available and there is sufficient data in the
BRENDA and BioCyc database.
Landscape of Interactions in the E. coli SMRN
The computationally reconstructed E. coli SMRN contains 1,669
unique interactions between 321 unique endogenous metabo-
lites and 364 unique enzymes (EC numbers) (Figure 1). The
vast majority (83%) of these interactions are inhibitory. Of the
700 unique EC numbers in the E. coli model, about half are
regulated by at least one native metabolite in E. coli. Similarly,
320 distinct native metabolites (of the total 1,000) regulate
at least one enzyme (Figures 2A and 2B). Figure 1 provides a tally
of interactions and kinetic constants recovered from the
BRENDA and BioCyc database. We additionally found that 325
of the 1,669 interactions in the SMRN are supported by 2 orCell Reports 20, 2666–2677, September 12, 2017 2667
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Figure 2. Overview of Small Molecule Inter-
actions from the BRENDA
(A and B) Statistics of the computationally re-
constructed E. coli SMRN, covering the pro-
portions (A) of 1,039 E. coli metabolites that are
inhibitors, activators, or both and (B) of 669 E. coli
enzymatic reactions that are inhibited, activated,
or both.
(C and D) Scatterplots depicting the number of
activating and inhibiting interactions in which (C)
each metabolite and (D) each reaction partici-
pates.more independent literature references, which may be treated in
the future as an informatic surrogate for the likelihood that the
interaction is functionally relevant in vivo.
Certain metabolites and EC numbers participated in excep-
tionally high numbers of regulatory interactions (Figures 2C and
2D). In particular, the cofactors ATP, AMP, ADP, PI, PPI, NADPH,
and GTP together with the metabolites cysteine, pyruvate, and
phosphoenolpyruvate (PEP) were the most frequent metabolite
regulators, participating in at least 15 interactions (both inhibitory
and activating). Notably, ATP was found to regulate 57 different
reactions, reflecting its important role as a global reporter of the
energetic status of the cell (Atkinson, 1968). Although not strictly
molecules, metal ions were found to comprise a significant frac-
tion of the group of small molecule regulators. Interestingly, po-
tassiumwas themost frequently reported activator, likely reflect-
ing the ability of monovalent cations to activate a broad group of
enzymes (Page and Di Cera, 2006). Divalent cations, on the other
hand, were among the most recurrent inhibitors, with zinc having
more than 50 reported interactions and copper, calcium,manga-
nese, mercury, iron, and magnesium each reported to inhibit
more than 20 different reactions.
Small molecules can regulate enzymes for which they are not
native substrates or products, potentially as a mechanism for
long-distance signaling between metabolic pathways without
direct connection via their reactants. Therefore, we investigated
the distance covered by small molecule regulation (i.e., the
shortest graph-distance between each regulatory metabolite
and its targeted enzyme), using the genome-scale stoichiometric2668 Cell Reports 20, 2666–2677, September 12, 2017network of E. coli as a scaffold. As
described in the Experimental Proced-
ures, this distance corresponds to the
number of reactions a metabolite must
traverse in order to reach a target
enzyme.We found that enzymes are typi-
cally regulated by metabolites that are in
their close vicinity. Specifically, 17% of
inhibitory interactions are also reactants
of the corresponding enzyme, 25% are
only one enzymatic step away, and 35%
are two steps away. Activating interac-
tions tend to have slightly longer range in-
teractions, with only 8% of activators
regulating enzymes that utilize them as
substrates (Figure S1).To obtain specific insight on how small molecule-enzyme
interactions operate across different metabolic pathways, we
used the genome-scale E. coli metabolic model (Orth et al.,
2010) to classify each reaction according to functional metabolic
subsystems.We found that most interactions in the E. coliSMRN
seem to target seven main subsystems/pathways: cofactor
biosynthesis, alternate carbon metabolism, nucleotide salvage
pathway, arginine/proline metabolism, nucleotide biosynthesis,
cell envelope biosynthesis, and glycolysis/gluconeogenesis
(Figure S2). Interestingly, some canonically high-flux pathways
(e.g., the tricarboxylic acid (TCA) cycle and the pentose phos-
phate pathway) were regulated by comparatively few metabo-
lites. It is possible that such pathways are sparsely regulated
by small molecules because they are mostly regulated transcrip-
tionally, as has been recently suggested for TCA cycle genes
(Chubukov et al., 2013; Gerosa et al., 2015).
Further mining of this rich dataset revealed pathway-specific
preferences for the regulatory targets of certain small molecules.
Inparticular, PEP, citrate, andAMPeachactivated 3ormore reac-
tions in the glycolysis/gluconeogenesis pathway, suggesting that
these threemetabolites actascritical sensorscontrolling theover-
all rate and direction of glucose metabolism. Similarly, a group of
nucleoside triphosphates, deoxynucleoside triphosphates, and
adenosine appear to specifically inhibit enzymes in three path-
ways related to nucleotide metabolism (nucleotide salvage, pu-
rine/pyrimidine biosynthesis, and prosthetic group biosynthesis),
perhaps reflecting a negative feedback loop for the maintenance
of adequate levels of various nucleotides (Figure S2).
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Figure 3. Small Molecule Regulatory Network of E. coli Central
Carbon Metabolism
Depiction of the small molecule regulatory interactions in the central carbon
metabolism of E. coli. Redmetabolites are inhibitors and greenmetabolites are
activators of the indicated reactions. Another view of this SMRN is given in
Figure S3, showing clearly which reactions are inhibited, activated, or both.Design Principles in the Regulation of Central Carbon
Metabolism
Central carbon metabolism, encompassing glycolysis, the
pentose phosphate pathway, and the TCA cycle, provides all
the energetic and biosynthetic precursors for the cell, and it is
known to be highly transcriptionally, post-translationally, and
allosterically regulated (Chubukov et al., 2014). The central meta-
bolism of E. coli is also one of the few parts of metabolism where
in vivo evidence is available to support the functional role of small
molecule regulation, e.g., in order to induce flux reversal (Link
et al., 2013). In silico efforts to model the response of central
metabolism to nutrient perturbations, combined with experi-
mental data, have highlighted the fact that our understanding
of the intricate regulation of central metabolism is incomplete
(Gerosa et al., 2015; Hackett et al., 2016; Kochanowski et al.,
2013; Link et al., 2013; Xu et al., 2012a).
Themajority of enzymes in E. coli’s central carbonmetabolism
are regulated (Figure 3; Figure S3), and they interact with more
small molecules than average in the SMRN (Figure S1), reflecting
the heavy research attention these pathways have historicallyattracted. Interestingly, some of the enzymes in central meta-
bolism are very heavily regulated, specifically those in upper
glycolysis (e.g., fbpase, pfk, and fba), terminal glycolysis (pck,
ppc, pps, and pyk), and the branching reactions of the TCA cycle
(mae, aceA, and icd). Conversely, some metabolites seem to
have amore central role in certain regions of central metabolism;
PEP, for instance, regulates six reactions in glycolysis (pfk, pgi,
fbpase, fba, pps, and pyk).
A glance at the structure of small molecule regulation in
E. coli’s central metabolism strongly suggests that the distribu-
tion of regulatory interactions is non-random and has likely
been shaped by evolution. What are the pressures selecting
for regulatory interactions in E. coli’s SMRN? In this regard, the
theoretical and experimental literature has proposed a variety
of thermodynamic and economic arguments to explain patterns
of SMR interactions in central carbon metabolism. Below, we
evaluate the consistency of each hypothesis with data from the
E. coli SMRN.
One frequently cited hypothesis is that small molecule regula-
tion is concentrated in those reactions exhibiting a large drop
in free energy (Stryer et al., 2002). To evaluate this possibility,
we acquired thermodynamic data for most metabolic reactions
using the component contribution method (Noor et al., 2013).
Using reactions’ DGo together with reaction stoichiometry and
standard physiological metabolite concentrations of substrates
or products, we calculated a reversibility index (denoted G)
quantifying the extent to which each reaction is thermodynami-
cally reversible (Noor et al., 2012). Using two complementary
methods, we did not find the distributions of G values for regu-
lated/unregulated reactions in central carbon metabolism to be
statistically different (p value < 0.3, Mann-Whitney U test;
p value = 0.1, gene set enrichment analysis; Figure 4B). The
same result was observed when repeating the analysis on all
available reactions in E. coli (p value < 0.5, Mann-Whitney
U test; p value = 0.25, gene set enrichment analysis; Figure 4A;
Table S4). While many irreversible reactions in central carbon
metabolism were indeed regulated by small molecules, a similar
proportion of reversible reactions were also regulated. In partic-
ular, we found reactions, like 6-phosphogluconolactonase in the
PP pathway (EC 3.1.1.31, log10(G) = 4.17), that do not have any
reported small molecule interactions yet exhibit a large drop in
free energy. Similarly, many reversible reactions have several
regulators, as in the case of succinyl-CoA synthetase (EC
6.2.1.5, log10(G) = 0.09), which is inhibited by NADH and alpha-
ketoglutarate, or glucose-6-phosphate isomerase (EC 5.3.1.9,
log10(G) = 0.44), which is inhibited by PEP and 6PGC. Taken
together, our data do not support the hypothesis that thermody-
namically irreversible reactions aremore likely to be regulated by
a small molecule.
A second hypothesis is that cells use small molecule regula-
tion to conserve precious metabolic resources by preventing
futile cycling. We observed several examples of interactions in
the E. coli SMRN supporting this possibility. For example, fbpase
and pfk catalyze opposing reactions, and their simultaneous
operation leads to futile cycling (Daldal and Fraenkel, 1983).
Two metabolites (citrate and PEP) serve as activators for fbpase
and as inhibitors for pfk, thus curbing this futile cycle (Figure 3). A
similar regulatory architecture can be found in the regulation ofCell Reports 20, 2666–2677, September 12, 2017 2669
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Figure 4. Thermodynamics, Saturation, and
Elasticity of Small Molecule Regulatory
Interactions in E. coli
(A and B) Comparison of reversibility indices (G)
(Noor et al., 2012) between regulated and un-
regulated reactions. jlog10(G)j reflects how much
freedom the reactants’ concentrations need for
reversing the flux. For instance, a reaction whose
jlog10(G)j > 3 would require a concentration range
of at least 1:103 (e.g., 30 mM–30 mM) in order to
reverse its direction. Physiological constraints
typically limit this range to 103–104. (A) shows
the cumulative distribution of jlog10(G)j for all re-
actions in the E. colimodel for which an equilibrium
constant could be computed using component
contributions (Noor et al., 2013). This means that
60%–70% of reactions are reversible, with virtually
no regard to whether they are regulated or not.
The difference between the distribution of jlog10(G)j
for regulated and unregulated reactions is not
significant (Mann-Whitney U test, p value < 0.5).
In (B), we focus only on reactions in central carbon
metabolism, where the difference is not significant
either (p value < 0.3).
(C) The distribution of measured metabolite con-
centrations, where the peak value is slightly below
1 mM.
(D) The histograms of KM and KI values are signifi-
cantly different (Mann-Whitney U test, p value <
0.005). For a more detailed comparison on a
single-metabolite basis, see Figure S6.
(E and F) Conversion of measured binding con-
stants to saturation levels using measurements
of metabolite concentrations across 13 conditions
further highlights the difference between sub-
strates (KM values) and inhibitors (KI values) (Mann-
Whitney U test, p value < 1072). When comparing
the distributions of scaled elasticities (F), we
find that inhibitors have significantly higher values
(p value < 1044), and they seem to have a bimodal
distribution that is split exactly at 0.5. Note that
the absolute elasticity value for inhibitors is exactly
equal to the saturation, therefore, the blue histo-
gram is the same in (E) and (F). For substrates,
however, the elasticity is equal to 1 minus the
saturation, so the red histogram in (F) is the mirror
image of the one in (E).the four reactions metabolizing PEP: PEP itself activates pyru-
vate kinase but inhibits the reverse reaction PEP synthase. Mov-
ing beyond anecdotal observations, we used a genome-scale
metabolic model (iJO1366; Orth and Palsson, 2012) to detect
reactions that can lead to futile cycling. We identified 58 non-
overlapping futile cycles, the majority of which comprise only
two reactions. Combining this information with the SMRN, we
found no statistically significant overrepresentation of small
molecule regulation in reactions that take part in futile cycling
(see the Supplemental Experimental Procedures). Our finding
here needs careful interpretation: the fact that futile cycle reac-2670 Cell Reports 20, 2666–2677, September 12, 2017tions are not more likely to be regulated
does not necessarily mean that conserva-
tion of resources is not important forfitness. For example, it might be that many futile cycles are not
regulated because they are in the periphery of metabolism and
do not carry high flux, thus making their lack of regulation not
very costly for the cell; or, perhaps, most of these futile cycles
are avoided by preventing the co-expression of all cycle en-
zymes simultaneously. Indeed, the fact that fbpase and pfk are
often co-expressed in E. coli might be a rare case due to the
importance of glycolysis and the need for rapid adaptation of
its flux direction.
Besides the prevention of futile cycles, conservation of re-
sources also can be achieved by avoiding wasteful biosynthetic
overproduction. This could be implemented by control of supply
and demand of amino acids or nucleotides. In particular, SMR in-
teractions can prevent large fluctuations/instability in the con-
centrations of biosynthetic end products via feedback inhibition.
It is, therefore, often hypothesized that allosteric regulation of the
branching reactions from central metabolism leading to amino
acid biosynthesis may achieve accurate supply/demand control
(Hofmeyr and Rohwer, 2011; Hofmeyr and Cornish-Bowden,
2000) and, thus, prevent unnecessary waste. Interactions in
the E. coli SMRN are consistent with this hypothesis: analysis
of the SMRN revealed that 16 of the 20 amino acids regulate their
own biosynthesis using a negative feedback loop, i.e., by inhib-
iting the first enzyme of their biosynthetic pathway (Figure S4).
The remaining non-feedback-inhibitory amino acids (glycine,
alanine, aspartate, and glutamate) are 4 of the 5 cheapest ones
in terms of the energetic investment required to produce them
(Akashi and Gojobori, 2002; Link et al., 2015).
In summary, we found that one of the common (thermody-
namic) hypotheses regarding the incidence of small molecule
regulation is not supported by data from the E. coli SMRN, and
we found only anecdotal evidence for an enrichment of regula-
tion in futile cycles. We did, however, find compelling support
for an economic role of SMR interactions via feedback inhibition
of biosynthesis pathways, at least for 16 of the 20 amino acids.
The four exceptions to this rule, however, might prove to be
interesting cases where having a regulatory interaction is more
costly than the benefit it provides to the cell. In the following
sections, we elaborate on this cost, and we quantify it using
metabolic control analysis.
How Is a Metabolite’s Role as Regulator and Substrate
Balanced?
Small molecule metabolites serve two fundamentally distinct
roles in the cell: one, as substrates for metabolic reactions,
and another, as regulatory molecules affecting the activity of en-
zymes and transcription factors (Gerosa and Sauer, 2011). How
does the cell balance these two responsibilities, especially in
bacteria that have no intracellular compartments that could offer
spatial separation (Alam et al., 2017)? More specifically, are the
cellular concentrations of these metabolites and the affinities
of their interactions with the different enzymes in E. coli tuned
such that they can inhibit some reactions while efficiently serving
as substrates for others? To address this question, we gathered
all reported Michaelis-Menten constants (KM) and inhibitory
half-saturation constants (KI). We decided to use these KM and
KI values as approximate indicators of a small molecule’s
metabolic operating point and regulatory operating point,
respectively.
We first evaluated whether KM and KI values were quantita-
tively similar to each other (KA values, or binding constants asso-
ciated with activating interactions, were not available in the
BRENDA and were thus excluded). As reported by others (Park
et al., 2016), in general, KI values tend to be higher than KM
values (Figure 4D; Mann-Whitney U test, p value < 0.005). A
more informative approach to evaluating differences in KM and
KI values is by a direct comparison with physiological metabolite
concentrations. For example, if a metabolite’s concentration is
much higher than all of its associated KM and KI values, thenall interactions related to this metabolite are approximately fully
saturated and any differences between KM and KI are not phys-
iologically meaningful. Here, we quantify the level of saturation
using the formula s=ðs+KSÞ, where KS is a binding constant
(either KM or KI) and s is the concentration of the substrate or in-
hibitor. For a substrate, the saturation represents the relative ac-
tivity of an enzyme compared to a case where s is very high and
the enzyme is fully activated (assuming all other parameters are
kept constant and the reaction obeys irreversible, mono-sub-
strate kinetics). We use this definition to identify physiologically
relevant differences between substrate and inhibitor affinities.
To apply the notion of saturation to our data, we obtained pre-
viously published metabolite concentrations in exponentially
growing E. coli cultures on 13 different carbon sources (Kocha-
nowski et al., 2017). For each unique binding constant/metabo-
lite concentration pair, we calculated the saturation level (332
enzyme-inhibitor-condition triplets and 798 enzyme-substrate-
condition triplets; Figure 4E). A comparison between substrate
and inhibitor saturation levels yielded a significant difference in
the saturation of inhibitor- and substrate-binding sites (Mann-
Whitney U test, p value < 1072). This suggests that, at physio-
logically relevant concentrations of metabolites, the majority of
substrate binding sites are at or near saturation, while inhibitor
sites are occupied but largely far from being saturated, as was
reported in the past (Bennett et al., 2009; Park et al., 2016).
Quantifying the Metabolic Response to Small Molecules
across Different Conditions and the Trade-Off between
Regulation and Enzymatic Activity
The results presented in Figure 4E indicate that approximately
one-third of the inhibitory interactions involved metabolites
whose concentrations were higher than the associated KI (satu-
ration level at least 0.5). This suggests that many enzymes are
operating below their maximal catalytic potential. Why would
metabolic enzymes be poised at such a point, well below
maximal activity? As we show below and in the Supplemental
Experimental Procedures, one possible explanation is a funda-
mental trade-off that enzymes face: in order to be responsive
to the abundance of metabolite regulators, enzymes must sacri-
fice some of their catalytic activity. Put another way, there is an
inherent cost associated with small molecule regulation; to
effectively regulate enzyme activity, an inhibitor must be at a suf-
ficiently high concentration. Using theoretical arguments from
metabolic control analysis (MCA), we prove that this trade-off
between activity and regulation is valid for a general class of
kinetic rate laws (e.g., competitive, noncompetitive, and uncom-
petitive inhibition), applying both to inhibitors and activators (see
the Supplemental Experimental Procedures).
The relevant quantity in MCA that leads to the finding above
is the scaled elasticity εvs , which quantifies how fluctuations
in the concentration of a metabolite S affect the rate of
reaction v. For substrates of reactions described by irreversible
Michaelis-Menten kinetics, the scaled elasticity is given by
ε
v
s = ðvv=vsÞ,ðs=vÞ= 1 s=ðs+KMÞ, i.e., it is maximized (equal
to 1) when the substrate-binding site is unsaturated ðS  KMÞ.
In this regime, a fluctuation in the concentration of substrate
leads to a linearly proportional change in the flux of the enzyme
(for an isolated enzyme, like in an in vitro assay). On the otherCell Reports 20, 2666–2677, September 12, 2017 2671
AB
Figure 5. Functional Role of Small Molecule-Enzyme Interactions in Central Metabolism
(A) The opposing relationship between elasticity and concentration for a prototypical substrate or inhibitor. In general, substrates have high elasticity at low
concentrations, while inhibitors have high elasticity at high concentrations.
(B) A heatmap of the median values of each metabolite’s elasticity values across all enzymes that utilize it as a substrate (left-hand side) and across all enzymes
inhibited by it (right-hand side). The different columns correspond to different growth conditions (batch growth on minimal media with single carbon sources,
samples in mid-exponential phase). Saturation levels were calculated using the formula [S]/([S] + KS), where KS is either the Michaelis-Menten coefficient (KM) or
the inhibition constant (KI), and, in turn, elasticities were calculated as described in the text. The numbers next to each metabolite in parentheses count the
number of different KM or KI values, respectively, that a metabolite has in our database (for different reactions). If a metabolite has more than one KM or KI value
(i.e., for more than one enzyme), the median of all elasticities is shown.
For more details, see Figure S5 and Tables S5, S6, S7, and S8.hand, the elasticity of non-cooperative, non-competitive inhibi-
tors I is described by εvI = ðvv=vIÞ,ðI=vÞ=  I=ðI+KIÞ (see Fig-
ure S5). Counterintuitively, this means that a reaction is most
sensitive to an inhibitor I when I is at high concentration and
the enzyme is strongly inhibited ðI[KIÞ. Conversely, when the
inhibitor concentration is low, its elasticity approaches zero2672 Cell Reports 20, 2666–2677, September 12, 2017and the flux cannot respond to changes in I. Therefore, sub-
strates and inhibitors are subject to opposite quantitative rela-
tionships describing their potential to regulate reactions (Fig-
ure 5A). Therefore, the saturation level has two complementary
consequences: first, it affects the elasticity (how sensitive the
reaction rate is to changes of the regulator level), and second,
Figure 6. Small Molecule Regulation across Kingdoms of Life
The BRENDA was mined for all reports of small molecule regulatory in-
teractions across all species. These interactions were aggregated by unique
metabolite-reaction pairs. For each interaction evident in at least 10 different
organisms and supported by evidence from at least 10 different published
studies, manual curation of the results followed. We identified the broad
phylogenetic taxon within which the interaction was present. Nearly all
conserved interactions are inhibitory, with three exceptions: the activation of
phosphofructokinase by three metabolites (AMP, ADP, and fructose-2,6-bi-
sphosphate), the activation of PEP carboxylase by G6P, and the activation of
pyruvate kinase by FDP.it determines the necessary amount of enzyme (because enzyme
that is not used at its full capacity needs to be compensated by
higher enzyme levels).
Thus, an alternative way of examining the difference between
KM and KI data is by translating estimates of saturation into elas-
ticities (which we treat as proxies for the metabolic response co-
efficient; see the Discussion and the Supplemental Experimental
Procedures). To simplify the calculation and avoid dependencies
betweenmultiple parameters andmetabolite concentrations, we
assumed that all reactions follow irreversible Michaelis-Menten
kinetics and all inhibitors are non-competitive. A detailed exam-
ination of elasticities, across the 13 different growth conditions,
further revealed the regulatory contribution of a set of centralmetabolites as substrates and inhibitors (Figures 4F and 5;
Tables S5, S6, S7, and S8). Interestingly, metabolites like IMP,
ATP, and ADP have very low elasticities as substrates (since
they are typically at saturating levels), whereas others (GMP
and AKG) have high substrate elasticities spanning from 0.7
to 0.9. As inhibitors, many metabolites are poised between
elasticities of 0.2 and 0.5, whereas some metabolites (e.g.,
GDP and ADP) have high elasticities across all conditions. A
higher elasticity could increase the flux response to changes in
these metabolites, which is supported by prior work, e.g., it
has been reported that ADP strongly regulates PRPP synthase
(prpps, EC 2.7.6.1) as a form of biosynthetic feedback inhibition
(Willemoe¨s et al., 2000), as well as fructose-1-phosphate kinase
(fruk, EC 2.7.1.56) as a mediator of end product inhibition
(Buschmeier et al., 1985).
Notably, the elasticity of several highly connected metabolites
in the SMRN (i.e., PEP and FDP) changes substantially between
environmental conditions. FDP has high inhibitory elasticities
when cells grow in a glycolytic mode (e.g., growth on glucose,
fructose, and mannitol), consistent with the proposed role of
FDP as a flux sensor in glycolytic conditions (Kochanowski
et al., 2013). Interestingly, PEP as an inhibitor has high (absolute)
elasticities on gluconeogenic carbon sources (e.g., pyruvate, ac-
etate, and succinate), operating antisymmetrically to FDP. This
regulatory design is critical for the adaptation to environmental
conditions, for example, for the control of the flux through phos-
phofructokinase (pfk), which PEP is known to inhibit (Fenton and
Reinhart, 2009). This inhibition is not needed though when cells
grow on glycolytic carbon sources like glucose. Interestingly, we
found that, on glycolytic carbons that can only support a slow
growth rate, PEP still has high elasticities (e.g., 0.38 and 0.36
for pfk when cells grow on galactose or mannose, respectively).
Small Molecule Regulation across Kingdoms of Life
While some central pathways of metabolism are nearly ubiqui-
tous, whole-cell metabolism varies substantially among different
organisms. At the coarsest resolution, some phylogenetic taxa
(e.g., bacteria and plants) can fix inorganic carbon while others
(e.g., animals) cannot. On the other hand, the architecture of cen-
tral carbon metabolism is broadly conserved across all king-
doms of life (Peregrı´n-Alvarez et al., 2003, 2009). However, there
is little understanding of the extent to which small molecule reg-
ulatory interactions are conserved across evolutionarily distant
taxa. Therefore, we analyzed all available data on small molecule
activators and inhibitors available in the BRENDA, stratifying
by the species in which the interaction was reported. We mined
these data for recurrence of a regulatory interaction between
a small molecule and EC number across different species. We
then focused on analyzing interactions that were (1) evident
in at least 10 different species and (2) supported by at least
10 different reports in the literature. A full list describing the
253 such interactions is available as Table S3.
Because of the high interest in modeling and understanding
of flux through central carbon metabolism, we focused our ef-
forts on understanding recurrent regulatory interactions in this
pathway (Figure 6). After excluding small ions and non-endoge-
nous metabolites, we identified 18 small molecule regulatory
interactions evident broadly across several phylogenetic taxa,Cell Reports 20, 2666–2677, September 12, 2017 2673
metabolite-enzyme
interactions
transcriptional
metabolite signals
combined
only metabolite-enzyme interaction
only transcriptional metabolite signal
any metabolite mediated regulation
Figure 7. Combined Architecture of Direct Small Molecule and
Indirect Transcriptional Regulation via Endogenous Metabolites in
E. coli
Amap of the reactions in central carbonmetabolism that are regulated directly
or indirectly bymetabolite(s). On the left are reactions that are reported to have
at least one metabolite-enzyme interaction. The middle diagram indicates
reactions that are indirectly regulated by metabolites via transcription; in each
case, the reaction is regulated by transcription factors that are recipients
of metabolic signals (i.e., Cra-FDP and Crp-cAMP), as reported in Kocha-
nowski et al. (2017). Some reactions, e.g., those in intermediate glycolysis, are
regulated exclusively by transcription. The map on the right overlays small
molecule and transcriptional regulation.which converged on the regulation of a small number of
enzymes: four nodes in glycolysis, phosphofructokinase (6 recur-
rent regulators), fructose bisphosphatase (2 recurrent regula-
tors), PEP carboxylase (3 recurrent regulators), and pyruvate
kinase (3 recurrent regulators). Surprisingly, we found few
conserved interactions in the TCA cycle, glyoxylate shunt, and
the nonoxidative branch of the PP pathway. In line with its role
as a committing step in glycolysis, phosphofructokinase was
subject to negative feedback control by two metabolites far
downstream in glucose catabolism, citrate and PEP, as well as
regulation by energy-related cofactors ATP, ADP, and AMP. In
contrast, pyruvate kinase was negatively regulated by ATP, but
also it was subject to feedforward activation by fructose-1,6
diphosphate (FDP). The counterintuitive activation of pyruvate
kinase by FDP has been shown (Xu et al., 2012b) to be important
for the rapid response of yeast to changes in environmental
glucose levels, by driving the accumulation of PEP for future
phosphorylation of glucose in glucose-depleted conditions.
Similarly, the inhibition of phosphofructokinase by PEP also
has been shown to be of critical importance in dynamic perturba-
tions in E. coli (Link et al., 2013).
Interestingly, several of the recurrent regulatory interactions
we identified were evident in only a subset of phylogenetic
taxa. In some cases, this was due to the absence of the enzyme
in a taxon (e.g., PEP carboxylase is only present in archaea, bac-
teria, and plants and the pentose phosphate pathway is not pre-2674 Cell Reports 20, 2666–2677, September 12, 2017sent in archaea). In other cases, small molecule regulation was
simply different across taxa, with potentially interesting implica-
tions. For example, pyruvate kinase was inhibited by L-alanine
in animals, but not in other phyla. In humans, this differential
regulation plays a role in disease: the inhibition of one splice iso-
form of pyruvate kinase (PKM2) by L-alanine (but not the other,
PKM1) contributes to the cancer-associated shift to aerobic
glycolysis by promoting the shunting of glucose-derived carbon
into biosynthetic pathways (Morgan et al., 2013).
DISCUSSION
The regulatory action of small molecules on enzymes and
other proteins ensures robust operation of metabolism upon dy-
namic changes. For central carbonmetabolism, metabolites can
directly (acting as effectors) or indirectly (acting as signals to
transcription factors) regulate the flux of almost all enzymatic re-
actions (Figure 7). While our understanding of transcriptional and
post-translational regulation of metabolism has benefited from
advances in sequencing and mass spectrometric technologies,
experimental challenges have hindered similar breakthroughs
in our understanding of the regulation of enzyme activity by small
molecule metabolites (Lindsley and Rutter, 2006). Our approach
here has been to leverage the fragmented wealth of published
biochemical data to generate an atlas of small molecule regula-
tion informatically, i.e., without performing additional laboratory
experiments. Our findings illustrate the dual architecture of small
molecule regulation and the underlying metabolic network, allow
us to test a common hypothesis about the connection between
regulation and thermodynamics, and enable us to compare
between metabolite concentrations and their respective binding
affinities to target enzymes.
Here we report a resource of experimentally evaluated inter-
actions between endogenous metabolites and enzymes. Impor-
tantly, the computational framework we developed is freely avail-
able (https://github.com/eladnoor/small-molecule-regulation),
and it can be readily applied to reconstruct the SMRN of an
arbitrary organism of choice, given a suitable genome-scale
metabolic model and adequate data in the BRENDA and BioCyc
database. Such a resource may guide future implementations of
kinetic models and also guide experiments designed to identify
novel and functionally relevant in vivo metabolite-protein interac-
tions. Most implementations of kinetic models so far do not ac-
count for all known small molecule enzyme interactions but rather
a subset of them (Khodayari and Maranas, 2016; Millard et al.,
2017). Using our SMRN, such kinetic models could be expanded
to include all relevant interactions, allowing for system-level eval-
uation of the topological properties of the system. Our SMRN
could also be instrumental in the understanding of the functional
role of different small molecule enzyme interactions, in combina-
tion with kinetic models. For example, an SMRN may prioritize
metabolite-enzyme pairs to be included in a kinetic model based
on the number of independent literature reports supporting their
existence or based on the elasticity of the interactions in different
conditions. Inaddition, theSMRNand itsassociated inhibitor con-
stants can be used as prior information to parameterize dynamic
models of metabolism, an approach that has proven to be suc-
cessful in E. coli and yeast (Hackett et al., 2016; Link et al., 2013).
A critical shortcoming of our approach is the inherent biases
of the BRENDA and Ecocyc data, i.e., the tendency for well-stud-
ied enzymes, pathways, and organisms to be overrepresented
in these databases. Indeed, one factor in selecting E. coli as
the organism of choice for reconstruction was the breadth of
studies conducted on its metabolism. One approach we took
to resolving this issue was identifying putatively high-confidence
edges in the SMRN, i.e., those with at least 2 independent liter-
ature reports supporting the interaction (Table S2; Figure S7).
This portion of the SMRN retains 325 (20%) of the total edges,
a figure an order of magnitude larger than the number of edges
included in typical kinetic models of metabolism. Furthermore,
wherever possible, we performed our analyses on the exhaus-
tively explored sub-network of central carbon metabolism, as
well as on the full genome-scale network. For example, in the
thermodynamic analysis, we indeed find a weak but statistically
significant signal when testing for enrichment of small molecule
regulation in irreversible reactions. However, when the analysis
is expanded to the full network, we no longer find a statistically
significant difference in small molecule regulation between
reversible and irreversible reactions. This might suggest that
the thermodynamic principle is most relevant for reactions with
high fluxes like those in central carbon metabolism and does
not apply more generally to the entire metabolic network.
Our theoretical analysis of a wide class of inhibiting and acti-
vating small molecules shows that, in general, there is a direct
trade-off between the elasticity of an effector and the reduction
in activity that is caused by its interaction with the enzyme.
Mathematically, if q is the relative activity of the enzyme (e.g.,
q= 1 x=ðx +KIÞ in the case of non-competitive inhibition), then
the absolute scaled elasticity is equal to


ε
v
x

 = 1 q (see the
Supplemental Experimental Procedures). We show that this
relationship between activity and elasticity holds for activators
and inhibitors alike. Therefore, using a small molecule effector
to regulate a flux always comes with the cost of effectively
lowering the activity of the enzyme. This cost of regulation might
be the reason why E. coli does not have end product inhibition
for 4 of its amino acid biosynthesis pathways. Perhaps, the
cost of regulation for these metabolically cheap amino acids is
larger than the energetic cost of overproduction.
To estimate the level of control imposed by a small molecule,
we made several simplifications. First, we assumed that all sub-
strates and inhibitors bind non-cooperatively and that inhibition
is not competitive. Second, because a detailed and accurate
representation of the kinetic form of each reaction rate law in
E. coli was unavailable, we estimated elasticities assuming irre-
versible, mono-substrate kinetics. In the Supplemental Experi-
mental Procedures, we explore the consequences of these
assumptions. In particular, we find that substrate elasticities
assuming irreversibility are generically upper bounds on revers-
ible substrate elasticities. Furthermore, we show that the elastic-
ity of a substrate in a bi-substrate reaction is (assuming identical
kinetic rate constants where applicable) generically a lower
bound on the corresponding elasticity, assuming a mono-sub-
strate rate law. Relaxing these assumptions can both strengthen
and weaken some of our conclusions, depending on the magni-
tude of their effect (which itself depends on detailed rate laws
and parameters), such as those in Figure 4.Perhaps more importantly, our results regarding elasticities
must be treated carefully when making inferences on metabolic
control. According to MCA, a high elasticity is a necessary
but not sufficient condition for high control of a flux by a metab-
olite. We treat interactions with high elasticity as cases where
high regulatory capacity is possible; in contrast, interactions
with low elasticity are likely to have little regulatory capacity.
A trade-off between enzyme activity and elasticity will therefore
translate to a trade-off between activity and regulation. To be
fully consistent with MCA, one would have to calculate all con-
trol coefficients for the inhibited reactions and apply MCA to
calculate response coefficients, which quantify the level of flux
control of a metabolite, something that is not in the scope of
our work. A tractable path forward for decoding the control of
flux by the SMRN is to integrate data on changes in in vivo
metabolite abundance across conditions/perturbations. As we
showed in Figure 5, doing so creates a map of the condition-
dependent regulatory capacity (i.e., the elasticity) of small mole-
cules, and it prioritizes interactions that appear particularly rele-
vant in a subset of conditions. For canonical interactions with
available data on binding affinities, this kind of analysis can be
used as a first step in understanding the importance of a regula-
tory interaction, perhaps by focusing on those interactions with
a particularly large change in elasticity between two conditions.
For instance, we found that certain metabolites (e.g., fructose
bisphosphate) may have a substantially higher inhibition capac-
ity in a subset of conditions. Doing so will likely add to the
rich composition of transcriptional, post-translational, and small
molecule regulatory interactions that we know to control meta-
bolic flux.
EXPERIMENTAL PROCEDURES
Assembly of the SMRN
Raw data were obtained from the BRENDA and BioCyc database. Scripts
for parsing the obtained data; filtering unwanted values (i.e., for mutants
or negative results); and mapping among BRENDA ligand IDs, Kyoto Ency-
clopedia of Genes and Genomes (KEGG) identifiers, and BiGG metabolite
IDs were written in Python and can all be found on GitHub (https://github.
com/eladnoor/small-molecule-regulation, available under an MIT license).
Likewise, all computations and analyses done for this paper can be found in
the same repository.
Genome-Scale Metabolic Model
All calculations involving the metabolic network of E. coli (i.e., distance
calculations, thermodynamics of regulated and unregulated reactions, and
such) were done using the iJO1366 metabolic model downloaded from the
BiGG website (http://bigg.ucsd.edu/models/iJO1366) (Orth and Palsson,
2012) and with the help of the cobrapy toolbox (https://opencobra.github.io/
cobrapy/) (Ebrahim et al., 2013).
Distance Calculations in the SMRN
First, we removed all the rows corresponding to cofactors from the genome-
scale stoichiometric matrix of E. coli (the full list of cofactors is provided in
the captions of Figure S1). Then, the matrix was converted into an undirected
bipartite graphwhere nodeswere eithermetabolites or reactions. An edge was
added between every reaction and all of its substrates and products. Then, the
distance between each metabolite and enzyme was calculated by first finding
the shortest path between the two on the bipartite graph and counting the
number of enzyme nodes along that path (i.e., excluding the metabolite nodes
and the target enzyme itself). For example, the distance between an enzyme
and one of its substrates is 0.Cell Reports 20, 2666–2677, September 12, 2017 2675
Cross-Species Analysis of Small Molecule Regulation
All data regarding activation or inhibition were extracted from the BRENDA.
The R package taxize (Chamberlain and Szo¨cs, 2013) was used to recover
taxonomic information using the species name provided in the BRENDA.
Activating/inhibiting interactions with the same ligand ID (regulating metabo-
lite) and EC number (target enzyme) were aggregated, and the number of
such unique entries for each taxonomic group was calculated. Additionally,
the number of unique literature references supporting each interaction was
recorded, in order to preclude cases where a single interaction reported
across multiple species was supported by a small number of independent
sources.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, and eight tables and can be found with this article online at
http://dx.doi.org/10.1016/j.celrep.2017.08.066.
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